Aethlon Medical (EJU) Financial Statements
Aethlon Medical Financial Overview
Aethlon Medical's market cap is currently $7.79M. The company's EPS TTM is $-11.70; its P/E ratio is -0.46; Aethlon Medical is estimated to report earnings on November 18, 2026, and the estimated EPS forecast is $-2.41. See an overview of income statement, balance sheet, and cash flow financials.
| Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 0.00 | $ 0.00 | $ 574.25K | $ 294.17K |
| Gross Profit | $ 0.00 | $ 0.00 | $ 0.00 | $ 574.25K | $ 294.17K |
| Operating Income | $ -7.29M | $ -9.34M | $ -12.64M | $ -11.90M | $ -10.42M |
| EBITDA | $ -6.81M | $ -13.04M | $ -11.85M | $ -11.79M | $ -10.30M |
| Net Income | $ -7.15M | $ -13.39M | $ -12.21M | $ -12.03M | $ -10.42M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 5.03M | $ 5.50M | $ 5.44M | $ 14.53M | $ 17.07M |
| Total Assets | $ 6.33M | $ 7.36M | $ 8.25M | $ 17.51M | $ 19.42M |
| Total Debt | $ 336.72K | $ 649.75K | $ 940.32K | $ 1.21M | $ 729.41K |
| Net Debt | $ -4.69M | $ -4.85M | $ -4.50M | $ -13.32M | $ -16.34M |
| Total Liabilities | $ 1.45M | $ 2.24M | $ 2.48M | $ 2.44M | $ 2.43M |
| Stockholders' Equity | $ 4.89M | $ 5.12M | $ 5.77M | $ 15.06M | $ 17.13M |
| Cash Flow | |||||
| Free Cash Flow | $ -7.00M | $ -7.65M | $ -10.38M | $ -11.45M | $ -10.12M |
| Operating Cash Flow | $ -7.00M | $ -7.65M | $ -10.13M | $ -10.51M | $ -9.77M |
| Investing Cash Flow | $ -3.70K | $ 0.00 | $ -250.87K | $ -943.11K | $ -349.19K |
| Financing Cash Flow | $ 6.52M | $ 7.73M | $ 1.29M | $ 8.91M | $ 17.37M |
Currency in USD